Literature DB >> 7365598

Systemic carnitine deficiency simulating recurrent Reye syndrome.

A M Glasgow, G Eng, A G Engel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7365598     DOI: 10.1016/s0022-3476(80)80571-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  17 in total

Review 1.  Interrelationships of liver and brain with special reference to Reye syndrome.

Authors:  J K Brown; H Imam
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Carnitine deficiency with cardiomyopathy presenting as neonatal hydrops: successful response to carnitine therapy.

Authors:  P Steenhout; C Elmer; A Clercx; D Blum; D Gnat; S van Erum; F Vertongen; E Vamos
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Decreased serum carnitine in valproate induced Reye syndrome.

Authors:  H Böhles; K Richter; E Wagner-Thiessen; H Schäfer
Journal:  Eur J Pediatr       Date:  1982-11       Impact factor: 3.183

Review 4.  Defects of fatty acid oxidation in skeletal muscle.

Authors:  D M Turnbull; K Bartlett; N J Watmough; I M Shepherd; H S Sherratt
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

5.  Systemic carnitine deficiency: benefit of oral carnitine supplements vs. persisting biochemical abnormalities.

Authors:  M Duran; J B de Klerk; S K Wadman; H R Scholte; R P Beekman; F G Jennekens
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

6.  Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. Evidence for alterations in tissue carnitine transport.

Authors:  C J Rebouche; A G Engel
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

7.  Carnitine metabolism and inborn errors.

Authors:  A G Engel; C J Rebouche
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

Review 8.  l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.

Authors:  K L Goa; R N Brogden
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

9.  Carnitine transport in cultured muscle cells and skin fibroblasts from patients with primary systemic carnitine deficiency.

Authors:  C J Rebouche; A G Engel
Journal:  In Vitro       Date:  1982-05

10.  Possible deleterious effect of L-carnitine supplementation in a patient with mild multiple acyl-CoA dehydrogenation deficiency (ethylmalonic-adipic aciduria).

Authors:  A Green; M A Preece; C de Sousa; R J Pollitt
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.